Ascendis Pharma (ASND) Q4 2025 Earnings Transcript

TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...

Ascendis Pharma A/S (ASND) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 11, 2026 4:30 PM ESTCompany ParticipantsChad Fugure - Vice President of Investor ...

Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff

Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to ...

AI is disrupting drug discovery faster than expected

Opening Bid Unfiltered is available on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. If you aren’t paying attention to the companies behind a new wave of AI-driven drug ...